Mounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forecast

benzinga.com/markets/earnings/25/10/48529099/mounjaro-and-zepbound-power-eli-lillys-54-revenue-jump-in-q3-hikes-2025-forecast

Eli Lilly and Co. (NYSE:LLY) on Thursday reported better-than-expected third-quarter earnings and boosted its annual forecast, sending the stock higher.
LLY stock is gaining positive traction. See the full story here
The U.S. weight loss drug giant reported quarterly revenue of $17.60…

This story appeared on benzinga.com, 2025-10-30 14:05:19.
The Entire Business World on a Single Page. Free to Use →